Male breast development or Gynecomastia has been linked to the medication Risperdal, made by Johnson & Johnson. Risperdal has been prescribed to millions of patients over the years and this negative side effect is most prominent in male patients who were prescribed the drug at a young age. Male breast tissue growth can be an uncomfortable, painful and embarrassing condition. Johnson & Johnson has made billions from the sale of Risperdal and hundreds of lawsuits have been filed against them. If you or someone you know has been affected by Gynecomastia because of Risperdal, we are here to help. You have the right to take action and we’ll be your advocate. Simply fill out the form for a free evaluation.

History of Risperdal induced Gynecomastia

Risperdal or Risperidone has been prescribed since 1994 as an antipsychotic medication used to treat schizophrenia (including adolescent schizophrenia), bipolar disorder, depression, turrets and other psychological conditions. Gynecomastia, which is growth of male breast tissue has been linked to Risperdal. The drug works by blocking dopamine. Studies have shown that when Risperdal blocks dopamine, the pituitary gland may start producing prolactin which is a hormone that stimulates the growth of breast tissue and promotes milk production. This increase in prolactin production can result in the growth of male breast tissue, a complication that often cannot be corrected without surgery. In minor cases, liposuction can correct the problem. In more severe cases, breast reduction surgery may be the only option.